5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with Leukemia L 1210 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balzarini, J; Bohman, C; De Clercq, E; Fridland, A; Herdewijn, P; Horská, K; Karlsson, A; Van Aerschot, A; Votruba, I; Wang, L | 1 |
Balzarini, J; De Clercq, E; Knauss, E; Matsuda, A; Stet, L; Wiebe, L | 1 |
Matsuda, A; Minakawa, N | 1 |
Matsuda, A; Minakawa, N; Sasaki, T; Takeda, T; Ueda, T | 1 |
Matsuda, A; Minakawa, N; Sasaki, T; Ueda, T | 1 |
5 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and Leukemia L 1210
Article | Year |
---|---|
Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Topics: Adenosine; Animals; Antineoplastic Agents; Cell Division; Deoxyguanine Nucleotides; Guanine; Guanosine; Guanosine Triphosphate; Humans; IMP Dehydrogenase; Leukemia L1210; Lymphocytes; Mice; Mycophenolic Acid; Purine Nucleotides; Ribavirin; Ribonucleosides; Ribonucleotides; Tumor Cells, Cultured | 1993 |
Metabolism of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase.
Topics: Animals; Antineoplastic Agents; IMP Dehydrogenase; Kinetics; Leukemia L1210; Mice; Ribonucleosides; Tritium; Tumor Cells, Cultured | 1998 |
Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
Topics: Animals; Antineoplastic Agents; Catalysis; Drug Design; Fluorouracil; Humans; IMP Dehydrogenase; Inhibitory Concentration 50; Leukemia L1210; Models, Chemical; Ribavirin; Ribonucleosides; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |
Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
Topics: Animals; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry; Humans; Leukemia L1210; Leukemia P388; Mice; Ribonucleosides; Structure-Activity Relationship | 1991 |
The design, synthesis and antileukemic activity of 5-alkynyl-1-beta-D-ribofuranosylimidazole-4-carboxamides.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Leukemia L1210; Mice; Ribonucleosides; Tumor Cells, Cultured | 1988 |